Cargando…

Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study

BACKGROUND: Mucopolysaccharidoses are heritable, metabolic diseases caused by deficiency in an activity of one of specific lysosomal enzymes involved in degradation of mucoplysaccharides (glycosaminoglycans). Among many medical problems of patients with mucopolysaccharidoses, there are frequent epis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Węgrzyn, Grzegorz, Kurlenda, Julianna, Liberek, Anna, Tylki-Szymańska, Anna, Czartoryska, Barbara, Piotrowska, Ewa, Jakóbkiewicz-Banecka, Joanna, Węgrzyn, Alicja
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142328/ https://www.ncbi.nlm.nih.gov/pubmed/15882450 http://dx.doi.org/10.1186/1471-2431-5-9

Ejemplares similares

Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients
por: Piotrowska, Ewa, et al.
Publicado: (2011)

Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2009)

Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder
por: Wijburg, Frits A, et al.
Publicado: (2013)

Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2013)

Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts
por: Moskot, Marta, et al.
Publicado: (2015)

Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
por: Kloska, Anna, et al.
Publicado: (2011)

Dosage Compensation in Females with X-Linked Metabolic Disorders
por: Juchniewicz, Patrycja, et al.
Publicado: (2021)

The model homologue of the partially defective human 5,10-methylenetetrahydrofolate reductase, considered as a risk factor for stroke due to increased homocysteine level, can be protected and reactivated by heat shock proteins
por: Grabowski, Michał, et al.
Publicado: (2016)

The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis
por: Moskot, Marta, et al.
Publicado: (2019)

X-chromosome inactivation patterns depend on age and tissue but not conception method in humans
por: Juchniewicz, Patrycja, et al.
Publicado: (2023)

Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development
por: Bruhn-Olszewska, Bożena, et al.
Publicado: (2017)

Synthetic genistein derivatives as modulators of glycosaminoglycan storage
por: Kloska, Anna, et al.
Publicado: (2012)

Murine Fibroblasts and Primary Hepatocytes as Tools When Studying the Efficacy of Potential Therapies for Mucopolysaccharidosis Type I
por: Węsierska, Magdalena, et al.
Publicado: (2022)

Activities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids
por: Moskot, Marta, et al.
Publicado: (2015)

The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children
por: Liberek, Anna, et al.
Publicado: (2012)

Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel VPS33A Variant with Comparison with Other Described Patients
por: Lipiński, Patryk, et al.
Publicado: (2022)

Nonsteroidal anti-inflammatory drugs modulate cellular glycosaminoglycan synthesis by affecting EGFR and PI3K signaling pathways
por: Mozolewski, Paweł, et al.
Publicado: (2017)

Comparison of growth dynamics in different types of MPS: an attempt to explain the causes
por: Różdżyńska-Świątkowska, Agnieszka, et al.
Publicado: (2022)

Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients
por: Cyske, Zuzanna, et al.
Publicado: (2023)

Cellular and Gene Expression Response to the Combination of Genistein and Kaempferol in the Treatment of Mucopolysaccharidosis Type I
por: Węsierska, Magdalena, et al.
Publicado: (2022)

Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
por: Żuber, Zbigniew, et al.
Publicado: (2023)

Immunological evaluation of patients with mucopolysaccharidosis (MPS)
por: Aranda, Carolina, et al.
Publicado: (2015)

Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene
por: Pronicka, Ewa, et al.
Publicado: (2011)

Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure
por: Pronicka, Ewa, et al.
Publicado: (2010)

Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts
por: Brokowska, Joanna, et al.
Publicado: (2023)

Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications
por: Pierzynowska, Karolina, et al.
Publicado: (2019)

Corrigendum: Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids
por: Moskot, Marta, et al.
Publicado: (2016)

Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids
por: Moskot, Marta, et al.
Publicado: (2015)

Corrigendum: Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids
por: Moskot, Marta, et al.
Publicado: (2016)

Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment
por: Gaffke, Lidia, et al.
Publicado: (2023)

Human pulmonary artery endothelial cells in the model of mucopolysaccharidosis VI present a prohypertensive phenotype
por: Golda, Adam, et al.
Publicado: (2015)

Molecular action of isoflavone genistein in the human epithelial cell line HaCaT
por: Smolińska, Elwira, et al.
Publicado: (2018)

Prevalence rates of mucopolysaccharidoses in Poland
por: Jurecka, Agnieszka, et al.
Publicado: (2014)

The Effect of Recombinant Human Iduronate-2-Sulfatase (Idursulfase) on Growth in Young Patients with Mucopolysaccharidosis Type II
por: Żuber, Zbigniew, et al.
Publicado: (2014)

Stress responses and replication of plasmids in bacterial cells
por: Wegrzyn, Grzegorz, et al.
Publicado: (2002)

Small Prokaryotic Proteins Interacting with Nucleic Acids
por: Węgrzyn, Alicja, et al.
Publicado: (2022)

A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients—A Qualitative and Quantitative Approach
por: Szymańska-Rożek, Paulina, et al.
Publicado: (2023)

Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature
por: Jurecka, Agnieszka, et al.
Publicado: (2013)

Diagnostic difficulties in patients with attenuated form of MPS VI
por: Opoka – Winiarska, V, et al.
Publicado: (2011)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
por: Baydakova, Galina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpb6bcnre5q9mt9mr00q0n8g7r